Yearly Archives: 2019

The Faces of Luminex: Yetzielisse Urgelles, Graphic Design

December 6th, 2019 / Christina Olivas

Whether it’s through our website, social media channels, or a conference booth, if you’ve seen Luminex content lately, then you’re already familiar with our talented creative services team. Today, we’re shining the spotlight on Yetzielisse Urgelles, a gifted graphic designer who joined our team in early 2018 after completing her BFA in graphic and web

Continue reading »

METHODS Special Issue: Clinical and Analytical Performance Data for NxTAG RPP

December 4th, 2019 / Hilary Graham

Highly scalable, multiplex molecular assay is comparable to xTAG RVP performance If you’ve ever used an assay based on xTAG® Technology, you may wonder how the newer NxTAG® Chemistry stacks up. A new publication in Methods uses clinical and analytical data from respiratory pathogen panels to demonstrate how both performance and workflow have improved with

Continue reading »

METHODS Special Issue: New Multiplex Assay for Vaccine Immunogenicity Testing

November 25th, 2019 / Hilary Graham

Recently developed test lowers cost and reduces sample volumes needed for evaluating combination vaccines Scientists at the Serum Institute of India have developed a new multiplex immunoassay to perform the mouse immunogenicity testing recommended in many countries for quality control in the production of combination vaccines. They chose xMAP® Technology to design the serological assay,

Continue reading »

The Faces of Luminex: Brett Osburn, Manufacturing

November 22nd, 2019 / Christina Olivas

Here at Luminex, we’re proud to design and manufacture the products we sell—whether we’re synthesizing dyes for multiplexing or building clinical assays. In our synthesis group, we count on Brett Osburn, Lead Manufacturing Chemist, to help ensure the quality of our products. He has two bachelor’s degrees: one in chemical engineering from Texas Tech University,

Continue reading »

Custom Assays: ‘If You Dream It, We Can Multiplex It’

November 20th, 2019 / Hilary Graham

Video presentation details assay development services from MilliporeSigma With new biomarkers being published every day, fewer and fewer scientists can get exactly what they need from an off-the-shelf immunoassay kit. That’s why MilliporeSigma offers extensive custom xMAP® Technology assay design and development services, which are showcased in this 10-minute video presentation from Mike Godeny, Head

Continue reading »

METHODS Special Issue: Multiplexing Enables More Robust Surveillance for Avian Influenza

November 4th, 2019 / Hilary Graham

New assay developed for routine poultry monitoring In the journal Methods, scientists from Wageningen Bioveterinary Research report the development of a multiplex assay for avian influenza. The assay is built on Luminex’s xMAP® Technology, and allows for serotyping all 16 hemagglutinin (HA) and 9 neuraminidase (NA) protein subtypes simultaneously. Testing for avian influenza (AI) is

Continue reading »

The Faces of Luminex: Larry Vaughan, Facilities Operations

October 25th, 2019 / Molly Frazier

At Luminex, we often get caught up discussing the ins and outs of our instruments and assays, but the impact our employees have goes beyond the products we design. Where would we be without reliable facilities and high-functioning workspaces? Our Facilities team does an enormous amount of work to ensure everything from office spaces to

Continue reading »

METHODS Special Issue: New Assays to Characterize Vaccination and Infection History

October 21st, 2019 / Hilary Graham

Single-plex targets developed will become components for future multiplex assays Scientists in the Waterboer lab at the German Cancer Institute have developed the building blocks for a multiplex assay that will make it possible to quickly interrogate a person’s history of infection and vaccination. In a paper from Methods, the team reports developing individual assays

Continue reading »

Webinar: Protein Conformational Analysis Goes High-Throughput with xMAP Technology

October 16th, 2019 / Hilary Graham

Technique provides critical data for development of monoclonal antibodies and biosimilars At a 2018 xMAP® Connect user group meeting, Xing Wang, President of Array Bridge, spoke about how his team is using xMAP Technology to streamline the development of new biologics and biosimilars for pharma/biotech scientists. The 30-minute presentation focuses on protein conformational analysis (PCA),

Continue reading »

METHODS Special Issue: A Universal Protocol for Attaching Any Peptide to Dyed Magnetic Beads

October 14th, 2019 / Hilary Graham

A new technique eliminates the use of monoclonal antibodies and is robust enough for field use Monoclonal antibodies may soon become a thing of the past. While their high selectivity and affinity for their targets once made them the “gold standard” for detection applications, the time it takes to generate one and the variability in

Continue reading »